2020
DOI: 10.1007/s11102-020-01099-z
|View full text |Cite
|
Sign up to set email alerts
|

Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 68 publications
0
2
0
Order By: Relevance
“…Analysis of a Brazilian kindred with congenital isolated GHD due to a homozygous mutation in the GH-releasing hormone (GHRH) receptor gene showed no serious deleterious effect of congenital isolated GHD on risks of vascular events and survival (114). However, this finding should not be extended to patients with hypopituitarism and AGHD, who present a distinct phenotype (115). Unfortunately, randomized clinical trials evaluating the effect of GH therapy on mortality in AGHD are unavailable.…”
Section: Gh Deficiency (Ghd) In Adultsmentioning
confidence: 99%
“…Analysis of a Brazilian kindred with congenital isolated GHD due to a homozygous mutation in the GH-releasing hormone (GHRH) receptor gene showed no serious deleterious effect of congenital isolated GHD on risks of vascular events and survival (114). However, this finding should not be extended to patients with hypopituitarism and AGHD, who present a distinct phenotype (115). Unfortunately, randomized clinical trials evaluating the effect of GH therapy on mortality in AGHD are unavailable.…”
Section: Gh Deficiency (Ghd) In Adultsmentioning
confidence: 99%
“…Although historical studies suggest cardio or cerebrovascular vascular damage in acquired GH deficiency (GHD) [ 12 , 13 ], more recent articles do not support this association, suggesting that vascular damage in acquired GHD may be linked to associated gonadal, thyroid, or cortisol deficits, their replacements and/or radiotherapy [ 14 , 15 ]. We have described a large cohort of individuals residing in Itabaianinha, in the Brazilian state of Sergipe, with severe short stature, but near normal ocular axial length [ 16 ], due to a congenital isolated GHD (IGHD), caused by the c.57 + 1G > A mutation in the GH releasing hormone receptor (GHRHR) gene ( GHRHR OMIM n.618157) [ 17 ].…”
Section: Introductionmentioning
confidence: 99%